Cell and Gene Commercialization

  1. How Platform Technologies Are Shaping The Gene Therapy Landscape 9/30/2024

    Leading experts in gene therapy discuss CMC strategy for platform technologies, product lifecycle management, and the role CDMOs play in moving the space forward.

  2. Increasing The CGT Field's Investment In Innovation 9/13/2024

    In this segment from the Cell & Gene Live! Event Modernizing CAR-T Manufacturing: Is Point Of Care The Future?, our expert panelists respond to an audience question about how the industry can increase investment in the field’s innovation.

  3. The Future Of Autologous CAR-T Manufacturing: Balancing Innovation With Improvement 9/12/2024

    Experts from last month's Cell & Gene Live event discuss the innovations seen in CAR-T manufacturing and shared their thoughts on the feasibility of decentralized and point-of-care models to address manufacturing challenges.

  4. 3 Strategies For Articulating A Coherent Product Value Story 9/3/2024

    These strategies are designed to help you navigate the intricate landscape of product development, ensuring that your innovation not only reaches the market but also achieves sustainable success in a competitive environment.

  5. Key Takeaways And Market Insights From The Inaugural ThinkLive Summit 8/30/2024

    The inaugural ThinkLive Cell and Gene Therapy Summit explored the industry’s dynamic landscape, highlighting collaboration, communication, and market access challenges.

  6. Advertising & Promotional Review Consulting 8/29/2024

    ProPharma has built the world’s leading and first full-service global solution dedicated to Advertising & Promotional Review. 

  7. Strategic Considerations For Success In Gene-Based Therapeutics Development 8/27/2024

    The forces that impact gene therapy development continue to evolve dramatically. This paper explores strategic considerations for regulatory, operational, and commercial success.

  8. CRISPR And The Commercialization Of Gene-Based Therapies 8/27/2024

    The importance of early collaboration between drug developers, manufacturers, and payers is becoming more evident, as it aids in the creation of meaningful clinical endpoints and the formulation of a viable market access strategy.

  9. Takeaways From Cencora's Inaugural Cell And Gene Therapy Summit 8/14/2024

    Collaboration, communication, and competition are key to advancing cell and gene therapy. Experts share insights from Cencora's inaugural CGT summit.

  10. Digital Transformation In Life Sciences: The Importance Of Data Strategy 8/8/2024

    Learn how to align data with business objectives, ensure clean and contextualized data, and establish comprehensive data standards and governance with a robust data strategy.